Context: LPIN1 is the phosphatidic acid phosphatase that produces 1,2-diacylglycerol, and thus it is related to the synthesis of triglycerides in the adipocyte. LPIN1 has a role in lipid synthesis and nuclear receptor coactivation, both of which may be involved in lipid homeostasis and metabolism. Among others, hypoxia and endoplasmic reticulum (ER) stress are being shown to be related to the adipose dysfunction found in human obesity. Objective: The aim of this study was to analyze LPIN1 gene expression in human adipose tissue in parallel with several hypoxia, angiogenic, ER stress and peroxisome proliferator-activated receptor (PPAR)-related genes in human obesity. Design and Patients: Gene expression was quantified in abdominal (subcutaneous and visceral) adipose tissue from 62 subjects. Results: We have shown a marked association between LPIN1 and PPARa gene expression both in subcutaneous and visceral adipose tissues. Similarly, a strong interdependence with vascular endothelial growth factor (VEGF) gene expression was also described; in fact, LPIN1 and VEGF expression levels were significantly decreased with obesity to a similar extent. Conclusion: These associations might suggest a possible role of LPIN1 in stress conditions that occur in chronic obesity and underlie insulin resistance.
Introduction
Adipose tissue dysfunction has a crucial role in the pathogenesis of obesity-related insulin resistance and type 2 diabetes. There is increasing evidence concerning the players involved in insulin resistance. First, adipose tissue helps maintain the metabolic homeostasis by buffering the flux of fatty acids in the circulation during the postprandial period, a function that is disturbed in obesity. 1, 2 Obesity and insulin resistance are characterized by an impaired capacity to appropriately switch between 'fed' (carbohydrate oxidation) and 'fasting' (lipid oxidation) metabolism. This mismatching between energy supply and demand may contribute over time to lipid accumulation in other tissues. 2 Second, an expanded adipose tissue is recognized by the abnormal secretion of adipokines. Moreover, increased lipid deposition in adipocytes leads to the production of proinflammatory cytokines, including TNF-a and IL-6. 3 Although adipocytes contribute to the altered synthesis of these mediators, the adipose cells responsible for the main production of inflammation factors are macrophagues and other stromal cells. 3 Third, adipose tissue expansion is said to be achieved initially by adipocyte hypertrophia. A disproportionate increase in cell dimensions lengthens the distance oxygen must diffuse, which may lead to a hypoxic state in enlarged adipocytes. Hypoxia unleashes two responses. The first is through hypoxia-inducible factor (HIF-1a) and the second is the unfolded protein response, which occurs in the endoplasmic reticulum (ER). 4, 5 HIF-1a is a key regulator in the response to alterations in oxygen tension and modulates the expression of genes that are involved in angiogenesis (such as vascular endothelial growth factor, VEGF), erythropoiesis, inflammation and glucose metabolism, 4 and HIF-1a mRNA is overexpressed in morbid obesity. 6 However, other authors have found no differences in HIF-1a gene expression in adipose tissue of lean and obese subjects, 7 and it has been proposed as a protein marker of hypoxia in human obesity. 8 Hypoxia has been shown to induce the expression of VEGF and the glucose transporter 1 (GLUT1) facilitative glucose transporter in in vitro-differentiated human adipocytes. 9, 10 These three players involved in the basis of obesity-induced insulin resistance are in fact interrelated. It has been proposed that hypoxia is the underlying cause of the inflammatory response in adipose tissue in obesity. 11 Cholesterol and free fatty acids accumulation in ER membranes promote ER stress and activate the unfolded protein response. 12,13 ER stress and the unfolded protein response are linked to major inflammatory and stress-signaling networks through several mechanisms (JNK, NF-kB, reactive oxygen species). Lipin 1 gene (LPIN1) is a gene having a role in lipid synthesis and nuclear receptor coactivation, both of which may have important effects on lipid homeostasis and metabolism.
14 Previous studies in vitro and in vivo have linked LPIN1 to the maintenance of metabolic homeostasis. Human LPIN1 mRNA expression levels in subcutaneous adipose tissue (SAT) are reduced in obesity. 15, 16 In addition, LPIN1 mRNA levels positively correlate with insulin sensitivity. 17, 18 Moreover, an inverse correlation with proinflammatory cytokines, 15 and positive correlations with lipid oxidation, uptake and lipolysis genes have been observed, 19 with a strong correlation between LPIN1 and peroxisome proliferator-activated receptor (PPAR)a in SAT in healthy young men. 19 Associations between LPIN1 gene expression and PPARg have also been found. 15 Lipin-1 was shown to induce gene expression by transcriptional activation of the gene encoding PPARa and through direct cooperative interactions with PPARa and PPARg coactivator 1a (PGC-1a). 20 Molecular function of LPIN1 has been identified as the phosphatidic acid phosphatase that produces 1,2-diacylglycerol, directly relating LPIN1 to the synthesis of triglycerides in the adipocyte. 21 By regulating phosphatidic acid cellular levels, LPIN1 may direct the cell toward triglyceride accumulation or toward phospholipid synthesis for the cellular membranes. 22 Moreover, it is known that adipogenic and angiogenic stimuli should be evoked in a coordinated manner for adipose tissue enlargement. 23 In this sense, we have analyzed LPIN1 gene expression in human adipose tissue in parallel with several hypoxia and ER stress genes in human obesity.
Research design and methods
Selection of patients for the adipose tissue study A cohort of 62 subjects was recruited at Hospital Universitari Joan XXIII (Tarragona, Spain). All subjects were of white origin and reported that their body weight had been stable for at least 3 months before the study. They had no systemic disease other than obesity, and all had been free of any infections in the month before the study. Liver and renal diseases were specifically excluded by biochemical workup. Visceral adipose tissue (VAT) and SAT samples were obtained from all 62 subjects. Samples were obtained during abdominal elective surgical procedures (cholecystectomy or surgery for abdominal hernia). The Hospital's Ethics Committee approved the study and informed consent was obtained from all participants. Subjects were classified as lean, overweight and obese by their body mass index (BMI) according to the World Health Organization criteria. 24 Using these criteria, there were 19 lean, 28 overweight and 15 obese subjects. Clinical, anthropometric and analytical characteristics are described in Table 1 . Collection and processing of samples. All patients had fasted overnight, at least 12 h before surgical procedure. Blood samples were collected before the surgical procedure from the antecubital vein, 20 ml of blood with EDTA (1 mg ml À1 ) and 10 ml of blood in silicone tubes. In all, 15 ml of collected blood was used for the separation of plasma. Plasma and serum samples were stored at À80 1C until analytical measurements were performed. Adipose tissue samples were collected, washed in phosphate-buffered saline, immediately frozen in liquid N 2 and stored at À80 1C.
Analytical methods. Glucose, cholesterol and triglyceride plasma levels were determined in an autoanalyzer (Hitachi 737, Boehringer Mannheim, Marburg, Germany) using standard enzyme methods. High-density lipoprotein cholesterol was quantified after precipitation with polyethylene glycol at room temperature (PEG-6000; Sigma-Aldrich Corp., St Louis, MO, USA). Plasma insulin was determined by radioimmunoassay (Coat-A-Count insulin; Diagnostic Products Corp., Los Angeles, CA, USA). Plasma glycerol levels were analyzed by using a free glycerol determination kit, a quantitative enzymatic determination assay (Sigma-Aldrich Corp.). Intra-and interassay CV were less than 6% and less than 9.1%, respectively. Non-esterified free fat acid serum levels were determined in an autoanalyzer (Advia 1200, Siemens AG, Munich, Germany) using an enzymatic method developed by Wako Chemicals (Neuss, Germany). The degree of insulin resistance was determined by the homeostasis model assessment of insulin resistance, as (glucose
25 Levels of soluble interleukin 6 (sIL-6) were measured by the highly sensitive quantitative sandwich enzyme immunoassay technique with the Human IL6 Quantikine HS ELISA Kit (R&D Systems, Oxon, UK).
Relative gene expression quantification. We analyzed relative mRNA expression levels in SAT and VAT, from the 62 subjects, of genes related to hypoxia, angiogenesis and ER stress. We selected HIF-1a as a hypoxia marker, and VEGF as an angiogenic marker induced by hypoxia. We also analyzed GLUT1 expression as it seems to be induced on conditions of hypoxia. Markers of the three different classes of ER stress transducers (C/EBP-homologous protein (CHOP10), which is induced by protein kinase RNA-like ER kinase (PERK); Heat shock protein HSP 90-alpha (HSP90), induced by activating transcription factor-6, and X-box binding protein-1 (XBP1) (Hac1p homolog), induced by inositol-requiring protein-1), were selected. PPAR family mRNA expression was also analyzed.
A total of 400-500 mg frozen adipose tissue was homogenized with an Ultra-Turrax 8 (Ika, Staufen, Germany). Total RNA was extracted by using RNeasy Lipid Tissue Midi Kit (QIAGEN Science, Hilden, Germany), and total RNA was treated with 55 U RNase-free DNase (QIAGEN) following the manufacturer's instructions.
Of the total RNA, 250 ng was reverse transcribed to cDNA using a high-capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Applied Biosystems, Foster City, CA, USA) in a final volume of 20 ml. Approximately, 2 ng of cDNA per gene and replicate (each reaction was performed in duplicate) were used for quantitative real-time PCR. Ct value for each sample was normalized with the expression of PPIA (cyclophilin A). Real-time quantitative PCR was performed on a 7900HT Fast Real-Time PCR System using commercial Taqman Assays ( Western blot. For western blot analysis, total protein extraction was performed in ice-cold Radio-Immunoprecipitation Assay (RIPA) buffer with protease inhibitors from SAT adipose biopsies. Proteins were resolved by electrophoresis in 10% SDS-PAGE and transferred to PVDF membranes (Millipore, Billerica, MA, USA) by electroblotting. The membranes were blocked in 5% nonfat dry milk in phosphate-buffered saline containing 0.01% Tween 20 for 1 h at room temperature and incubated with the primary antibody overnight at 4 1C, and then washed three times and incubated in a 1:2000 to 1:4000 dilution of anti-rabbit or anti-mouse antibodies (Amersham-GE Healthcare, Buckinghamshire, England). The western blots were assayed using an antihuman Lipin-1 antibody, 26 Statistical analysis. Statistical analysis was performed by using the Statistical Package for the Social Sciences software, Table 2 Analysed genes and TaqMan probes Gene (GeneBank Accession) TaqMan gene expression assay 
Results
Interaction between LPIN1 gene expression with clinical and metabolic variables SAT LPIN1 gene expression showed a bivariate negative correlation with BMI, waist circumference, fasting triglycerides, glucose, serum insulin levels, homeostasis model assessment (HOMA) index and systolic blood pressure. VAT LPIN1 was found to be negatively correlated with BMI, waist and insulin (Table 3a) .
We next performed regression analysis by creating a model for each depot: SAT LPIN1 gene expression was assessed to be related to BMI, plasma triglycerides, homeostasis model assessment and systolic blood pressure. Age and gender were assessed as confounding variables. Results showed that SAT LPIN1 gene expression was mainly related to homeostasis model assessment index (R ¼ 0.797 and Po0.001). The VAT LPIN1 model included BMI and insulin as independent variables, and the influence of age and sex was controlled. Results showed that VAT LPIN1 was mainly related to BMI (R ¼ 0.554, Po0.001).
LPIN1 gene expression profile in adipose tissue depots
The correlation analyses between LPIN1 and the remaining studied genes within each adipose depot are shown in Table 3b . No association was observed with H1F1a gene expression either in SAT or in VAT depots, whereas a strong, positive association with VEGF and GLUT1 was found in both SAT and VAT. Similarly, a positive correlation between several ER stress genes (CHOP10, HSP90 and XBP1 in SAT and CHOP10 in VAT) was observed. PPAR family genes showed a strong, positive correlation in SAT with the three studied genes (a, d and g), whereas VAT LPIN1 was positively associated with PPARa and PPARd (Table 3b) .
To strengthen the independence of these associations as predictors of LPIN1 expression, a multiple regression analysis model was constructed for each depot. In the SAT model, homeostasis model assessment index and mRNA expression of subcutaneous marker genes for angiogenesis (VEGF), ER stress (CHOP10, HSP90, XBP1), GLUT1 and the PPAR family (PPARa-g) were selected as independent variables. The result showed that the model had a multiple correlation coefficient (R) of 0.934 and that SAT LPIN1 was mainly predicted by SAT PPARa (Po0.001) and SAT VEGF (P ¼ 0.001). In the VAT model, BMI and visceral marker genes for ER stress (CHOP10), hypoxia-induced markers (GLUT1 and VEGF), and the PPAR family (PPARa, d) were included as independent variables. The result showed that the model had an R ¼ 0.885 and that VAT LPIN1 was predicted by VAT PPARa (Po0.001) and VAT VEGF (Po0.001).
In addition, the expression patterns of the 10 genes were analyzed by the hierarchical cluster analysis to study the relationship of LPIN1 with PPAR transcription factors and The algorithm proceeded in a recursive manner to build the tree structure step by step. In SAT and VAT, LPIN1 expression levels were first clustered with PPARa expression levels (SCC ¼ 0.7298 in SAT and SCC ¼ 0.7779 in VAT) and then with VEGF (SCC ¼ 0.7098 in SAT and SCC ¼ 0.6577 in VAT). These associations were clustered with PPARg in SAT (SCC ¼ 0.6377) or with GLUT1 in VAT (SCC ¼ 0.5720). The following clusters had an SCC o0.5 ( Figure 1 ).
Expression profile according to obesity classification
Next, we aimed to analyze the expression levels of these interrelated genes in obesity. LPIN1 and VEGF were significantly downregulated in obesity to a similar extent (Figure 2a ). No differences were observed in expression levels of hypoxia marker HIF-1a and ER stress genes (CHOP10, HSP90, XBP1) when comparing the obesity groups. Only subcutaneous PPARa and PPARg showed significant differences (P ¼ 0.037 and P ¼ 0.022, respectively). Post hoc tests evidenced that there were significant differences only between controls and subjects with overweight for SAT PPARg (P ¼ 0.017). Protein levels were analyzed in some of the samples (3-6 for each group). Lipin-1 protein levels were significantly downregulated in overweight and obese subjects (P ¼ 0.028), and VEGF protein also showed a tendency to be downregulated (P ¼ 0.056), whereas PPARa showed no differences between the obesity groups (P ¼ 0.248) (Figure 2b ).
Discussion
We have shown a marked association between LPIN1 and PPARa gene expression both in subcutaneous and VATs. The strong relation between LPIN1 and PPARa gene expressions observed in our subjects, regardless of adipose tissue localization, might suggest a possible role of LPIN1 as a sensor of energy balance and lipid metabolism in human adipose tissue. Similarly, a strong interdependence with VEGF gene expression is also described. Angiogenesis and adipogenesis are mutually necessary for the expansion of adipose tissue. The lower levels of these genes in obesity may limit adipogenesis in abdominal adipose tissue.
LPIN1 and PPARa expression are positively correlated in both SAT and VAT There is evidence that LPIN1 may have acted as a transcriptional coactivator in several tissues, including adipose tissue. In liver, lipin-1 expression is required for the expression of the nuclear receptor PPARa in fasting states, facilitating fatty acid oxidation, 20 and a highly significant correlation between LPIN1 and genes involved in fatty acid metabolism, mainly PPARa gene, has been described in SAT taken from healthy men. 19 PPARa is expressed mainly in metabolically active tissues such as liver and skeletal muscle. Though PPARa is expressed at relative low levels compared with PPARg in adipose tissue (about 12% in our samples), an upregulation of PPARa by the chronic activation of adipocyte b-adrenergic receptors has been described and is inversely correlated with local inflammatory responses in mice. 28 In human adipocytes, ectopic expression of PGC1-a, a coactivator of PPAR family, switches on genes involved in fatty acid oxidation and the mitochondrial respiratory chain. 29 It is hypothesized that a major role of PPARa is to direct mobilized fatty acids toward mitochondrial oxidation and away from extracellular efflux-limiting adipose inflammation and its impact on systemic insulin sensitivity. 28 The positive PPARa association described with LPIN1 levels links both genes in a coordinated task during lipolytic stress that could reduce free fatty acids released by adipocytes as an effective means of limiting insulin resistance.
LPIN1 expression is positively correlated with hypoxia-and ER stress-induced genes in SAT and in VAT We have also addressed the relationship between human LPIN1 gene expression and genes related to hypoxia and ER stress in adipose tissue. In our study, positive correlations between some hypoxia-induced (GLUT1 and VEGF) and LPIN1 and VEGF in human adipose tissue M Miranda et al some ER stress genes (CHOP10, XBP1 and HSP90) and LPIN1 expression levels were observed. No differences in the hypoxia marker (HIF-1a) and ER stress genes across the different BMI classification groups were observed. Although the HIF-1a mRNA level was found to be increased in adipose tissue in obese mice models 30 and in human severe obesity, 6 another study did not find such an increase. 7 Thus, HIF-1a mRNA expression has been questioned and it has been proposed as a protein marker instead. 8 These results may at first seem counterintuitive compared with animal models, 31 although animal models of obesity may represent an active, non-stable form of adipose tissue expansion in which many mechanisms of lipogenesis and stresses are turned on before definite weight stabilization; in contrast, the subjects in our cohort are stable obese. For instance, it has been described that stable obese people have a limited lipogenic capacity in adipose tissue. 32 Rapid enlargement may deserve a more aggressive inflammatory and hypoxic environment in adipose tissue than in stable weight subjects. Regarding VEGF, it was clearly downregulated in parallel with LPIN1 in the overweight and obese cohorts. LPIN1 protein showed significant lower levels in subjects with overweight and obesity, whereas VEGF evidenced a tendency to be downregulated at the protein level without reaching significance, probably because of the small sample size. In fact, recent reports in obese mice models showed a downregulation of VEGF mRNA in adipose tissue despite an upregulation of HIF-1a. Figure 2 Gene expression levels in relation to obesity in SAT and VAT (a) and protein expression levels in SAT relative to lean subjects (b) (n ¼ 3-6 per group) with a representative western blot (lower panel). Significant differences: *, Po0.01; # Po0.05 vs lean.
LPIN1 and VEGF in human adipose tissue M Miranda et al subjects. 35 In human obesity, although the VEGF protein has been found to be increased in circulation, 36, 37 lower adipose tissue oxygen partial pressure in SAT of overweight/obese subjects did not induce an increase in hypoxia targets such as VEGF. 35 Angiogenesis is needed for efficient preadipocyte differentiation, but neovascularization is not triggered without adipocyte differentiation. 23 VEGF had neither a proliferative nor an adipogenic effect in human preadipocytes. 38 In this context, it is reasonable to find a positive association between LPIN1 and VEGF expression levels. Decreased levels of both LPIN1 and VEGF in adipose tissue of overweight and obese subjects may alternatively be interpreted as an adaptive process to counteract adipose tissue expansion. Along these lines, Pasarica et al 35 proposed that the failure of the vasculature to expand with increasing (subcutaneous) obesity might limit adipogenesis in adipose tissue and that lower oxygenation drives inflammation and not by activating the classic hypoxia pathway and VEGF.
Despite the useful information that provides these human data, there are still some limitations that must be acknowledged. Although mRNA quantification may highlight changes that occur in obesity, differences in transcript levels may not reflect changes at the protein level. We have tried to address this question by quantifying the protein levels, although the sample size limitation should be recognized. Nevertheless, we would like to draw attention to the fact that further studies are clearly required to examine the functional significance of these associations and to extend these results to the protein activity or signaling pathways.
In summary, we have analyzed the LPIN1 expression profile in abdominal adipose depots in relation to hypoxia, ER stress and angiogenesis. SAT and VAT have shown similar mRNA expression profiles. In the analysis of the independence of the observed associations, LPIN1 seems to be positively related to PPARa and VEGF mRNA levels in both depots. These associations may point to a possible role of LPIN1 in stress conditions that occur in chronic obesity and underlie insulin resistance.
